Analysts are piling on the praise for Vertex Pharmaceuticals, reaffirming bullish ratings even as the stock slightly fumbles ...

Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...

Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...

If it’s been a while, allow us to reintroduce you to this killer core move because it’s *actually* worth doing. Russian ...

As previously reported, Cantor Fitzgerald assumed coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and a price target of ...

When an electric current passes through some materials, it generates a voltage perpendicular to the direction in which the ...

Discover Google's new Veo-2 AI video generator transforming content creation with text-to-video and image-to-video ...

This rating is the official handicap rating and is assigned to a dog by racing bodies based on the merits of its previous racing performances, with a greater emphasis on recent form.

Shares of Vertex have rallied, even amid the broader stock market sell-off. The company is diversifying beyond its dominance in cystic fibrosis treatments. Several catalysts in 2025 support a ...

This rating is the official handicap rating and is assigned to a dog by racing bodies based on the merits of its previous racing performances, with a greater emphasis on recent form.